These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14501786)

  • 1. Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease.
    Hauck EW; Hauptmann A; Weidner W; Bein G; Hackstein H
    J Urol; 2003 Oct; 170(4 Pt 1):1443-6. PubMed ID: 14501786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology.
    Nachtsheim DA; Rearden A
    J Urol; 1996 Oct; 156(4):1330-4. PubMed ID: 8808864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there an immunogenetic basis for Peyronie's disease?
    Leffell MS
    J Urol; 1997 Jan; 157(1):295-7. PubMed ID: 8976283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigens in Peyronie's disease.
    Rompel R; Mueller-Eckhardt G; Schroeder-Printzen I; Weidner W
    Urol Int; 1994; 52(1):34-7. PubMed ID: 8140677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA association of idiopathic Peyronie's disease: an indication of autoimmune phenomena in etiopathogenesis?
    Rompel R; Weidner W; Mueller-Eckhardt G
    Tissue Antigens; 1991 Sep; 38(3):104-6. PubMed ID: 1796451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic and bacteriological aspects of Peyronie's disease.
    Ralph DJ; Schwartz G; Moore W; Pryor JP; Ebringer A; Bottazzo GF
    J Urol; 1997 Jan; 157(1):291-4. PubMed ID: 8976282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics and immunology of Peyronie's disease.
    Noss MB; Day NS; Christ GJ; Melman A
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S127-32. PubMed ID: 11035400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1-antitrypsin levels and genetic variation of the alpha-1-antitrypsin gene in Peyronie's disease.
    Hauck EW; Hauptmann A; Haag SM; Bohnert A; Weidner W; Bein G; Hackstein H
    Eur Urol; 2004 Nov; 46(5):623-8; discussion 628. PubMed ID: 15474273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie's disease.
    Hauck EW; Hauptmann A; Schmelz HU; Bein G; Weidner W; Hackstein H
    J Urol; 2003 Jan; 169(1):369-72. PubMed ID: 12478192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-association of Peyronie's disease with HLA B7 cross-reactive antigens.
    Leffell MS; Devine CJ; Horton CE; Somers KD; Dawson D; Vande Berg JS; Bluemink GG; Wright GI
    J Urol; 1982 Jun; 127(6):1223-4. PubMed ID: 6979636
    [No Abstract]   [Full Text] [Related]  

  • 11. Peyronie's disease: a newly recognized autosomal-dominant trait.
    Bias WB; Nyberg LM; Hochberg MC; Walsh PC
    Am J Med Genet; 1982 Jun; 12(2):227-35. PubMed ID: 6213155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective analysis of 16S rDNA as a highly sensitive marker for bacterial presence in Peyronie's disease plaques.
    Hauck EW; Domann E; Hauptmann A; Weidner W; Chakraborty T; Hossain HM
    J Urol; 2003 Nov; 170(5):2053-6. PubMed ID: 14532852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunological features of Peyronie's disease.
    Ralph DJ; Mirakian R; Pryor JP; Bottazzo GF
    J Urol; 1996 Jan; 155(1):159-62. PubMed ID: 7490821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of histocompatibility antigens of the B7 cross-reacting group with Peyronie's disease.
    Willscher MK; Cwazka WF; Novicki DE
    J Urol; 1979 Jul; 122(1):34-5. PubMed ID: 458986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction.
    Jarow JP; Lowe FC
    J Urol; 1997 Oct; 158(4):1388-90. PubMed ID: 9302127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening.
    Mulhall JP; Creech SD; Boorjian SA; Ghaly S; Kim ED; Moty A; Davis R; Hellstrom W
    J Urol; 2004 Jun; 171(6 Pt 1):2350-3. PubMed ID: 15126819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of Peyronie's disease with HLA B7 cross-reactive antigens. A case report of identical twins.
    Ziegelbaum M; Thomas A; Zachary AA
    Cleve Clin J Med; 1987; 54(5):427-30. PubMed ID: 3499260
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical characteristics of Peyronie's patients with notching deformity.
    Cakan M; Akman T; Oktar T; Gurkan L; Celtik M; Kadioglu A
    J Sex Med; 2007 Jul; 4(4 Pt 2):1174-8. PubMed ID: 17662024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penile vascular evaluation of men with Peyronie's disease.
    Lopez JA; Jarow JP
    J Urol; 1993 Jan; 149(1):53-5. PubMed ID: 8267684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
    Goldstein I; Lipshultz LI; McLane M; Hu Y; Xiang Q; Liu G; Vijayan S; Gelbard MK
    J Urol; 2020 Jun; 203(6):1191-1197. PubMed ID: 31922462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.